Clinical Trial: Empagliflozin in Heart Failure Dialysis Patients
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Heart Failure
Study Type: INTERVENTIONAL
Official Title: Safety and Efficacy of Empagliflozin on Heart Failure Dialysis Patients
Brief Summary:
Empagliflozin is not still approved for glomerular filtration rate < 20 cc/min/1.73m2.Considering the cardiac and renal benefits of this drug, the evaluation of the safety and efficacy of Empagliflozin for heart failure dialysis patients seems to be mandatory.
Read more